MK-677 (Ibutamoren)
Prescription OnlyOverview
MK-677 (Ibutamoren) is technically a non-peptide growth hormone secretagogue but is universally discussed in peptide communities. Unique for its oral administration (rare for this class). Carries more side effect concerns than injectable GH peptides including elevated cortisol and prolactin. Available through some Australian clinics.
Australian Scheduling
Schedule 4 (Prescription Only). Enforcement is stable. Oral administration makes it distinct from injectable peptides.
Access Pathway
Available through 6 identified Australian providers. Oral administration means it does not require compounding for injection.
For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.